David Rosmarin
Dermatology · Tufts Medical Center · Tufts Medical Center, Department of Dermatology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Rosmarin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:52 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06561321 · Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar KeratodermaIndiana University · active not recruiting · Palmoplantar Keratoderma · principal investigator
- Ph2NCT04306965 · Apremilast 30 mg Twice Daily (BID) Combined With DupilumabTufts Medical Center · completed · Atopic Dermatitis · principal investigator
- Ph2NCT04299503 · Topical Crisaborole in Patients with Alopecia AreataTufts Medical Center · withdrawn · Alopecia Areata · principal investigator
- Early Ph1NCT03159936 · Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)Tufts Medical Center · terminated · Discoid Lupus Erythematosus, Systemic Lupus Erythematosus · principal investigator
- Early Ph1NCT03099980 · Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis SuppurativaTufts Medical Center · completed · Hidradenitis Suppurativa · principal investigator
- Ph2NCT02809976 · Topical Ruxolitinib for the Treatment of VitiligoTufts Medical Center · completed · Vitiligo · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:52 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- 240 citationsRCR 21.8
- 215 citationsRCR 11.9
- Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials.Br J Dermatol · 2023141 citationsRCR 19.2
- Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.J Allergy Clin Immunol · 202296 citationsRCR 8.0
- 79 citationsRCR 5.2
- Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.J Am Acad Dermatol · 202069 citationsRCR 5.1
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.J Am Acad Dermatol · 201858 citationsRCR 3.1
- Religious vs. conventional cognitive behavioral therapy for major depression in persons with chronic medical illness: a pilot randomized trial.J Nerv Ment Dis · 201547 citationsRCR 2.9
- A randomized controlled evaluation of a spiritually integrated treatment for subclinical anxiety in the Jewish community, delivered via the Internet.J Anxiety Disord · 201046 citationsRCR 2.1
- 43 citationsRCR 6.2